Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 61 to 66 of 66 entries
Sorted by: Best Match Show Resources per page
Cushing's syndrome Part 1: Journey to Improving Diagnosis and Outcomes.

Best practice & research. Clinical endocrinology & metabolism

Fleseriu M.
PMID: 33752993
Best Pract Res Clin Endocrinol Metab. 2021 Jan;35(1):101520. doi: 10.1016/j.beem.2021.101520. Epub 2021 Mar 13.

No abstract available.

Cite
Fleseriu M. Cushing's syndrome Part 1: Journey to Improving Diagnosis and Outcomes. Best Pract Res Clin Endocrinol Metab. 2021;35(1):101520doi: 10.1016/j.beem.2021.101520.
Fleseriu, M. (2021). Cushing's syndrome Part 1: Journey to Improving Diagnosis and Outcomes. Best practice & research. Clinical endocrinology & metabolism, 35(1), 101520. https://doi.org/10.1016/j.beem.2021.101520
Fleseriu, Maria. "Cushing's syndrome Part 1: Journey to Improving Diagnosis and Outcomes." Best practice & research. Clinical endocrinology & metabolism vol. 35,1 (2021): 101520. doi: https://doi.org/10.1016/j.beem.2021.101520
Fleseriu M. Cushing's syndrome Part 1: Journey to Improving Diagnosis and Outcomes. Best Pract Res Clin Endocrinol Metab. 2021 Jan;35(1):101520. doi: 10.1016/j.beem.2021.101520. Epub 2021 Mar 13. PMID: 33752993.
Copy Download .nbib Format: NLM
Menopausal hormone therapy in women with medical conditions.

Best practice & research. Clinical endocrinology & metabolism

Kapoor E, Kling JM, Lobo AS, Faubion SS.
PMID: 34583890
Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101578. doi: 10.1016/j.beem.2021.101578. Epub 2021 Sep 10.

Hormone therapy is the most effective treatment for menopause-related symptoms. Current evidence supports its use in young healthy postmenopausal women under the age of 60 years, and within 10 years of menopause, with benefits typically outweighing risks. However, decision...

Cite
Kapoor E, Kling JM, Lobo AS, et al. Menopausal hormone therapy in women with medical conditions. Best Pract Res Clin Endocrinol Metab. 2021;35(6):101578doi: 10.1016/j.beem.2021.101578.
Kapoor, E., Kling, J. M., Lobo, A. S., & Faubion, S. S. (2021). Menopausal hormone therapy in women with medical conditions. Best practice & research. Clinical endocrinology & metabolism, 35(6), 101578. https://doi.org/10.1016/j.beem.2021.101578
Kapoor, Ekta, et al. "Menopausal hormone therapy in women with medical conditions." Best practice & research. Clinical endocrinology & metabolism vol. 35,6 (2021): 101578. doi: https://doi.org/10.1016/j.beem.2021.101578
Kapoor E, Kling JM, Lobo AS, Faubion SS. Menopausal hormone therapy in women with medical conditions. Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101578. doi: 10.1016/j.beem.2021.101578. Epub 2021 Sep 10. PMID: 34583890; PMCID: PMC8648973.
Copy Download .nbib Format: NLM
Genetics of congenital central hypogonadism.

Best practice & research. Clinical endocrinology & metabolism

Grinspon RP.
PMID: 34799236
Best Pract Res Clin Endocrinol Metab. 2021 Nov 10;101599. doi: 10.1016/j.beem.2021.101599. Epub 2021 Nov 10.

The diagnostic suspicion of congenital central hypogonadism is based on clinical signs. Biochemical confirmation is challenging, especially after the postnatal activation stage of the hypothalamic-pituitary-testicular axis. Sertoli cell markers, like AMH and inhibin B, have become useful tools for...

Cite
Grinspon RP. Genetics of congenital central hypogonadism. Best Pract Res Clin Endocrinol Metab. 2021;101599doi: 10.1016/j.beem.2021.101599.
Grinspon, R. P. (2021). Genetics of congenital central hypogonadism. Best practice & research. Clinical endocrinology & metabolism, 101599. https://doi.org/10.1016/j.beem.2021.101599
Grinspon, Romina P. "Genetics of congenital central hypogonadism." Best practice & research. Clinical endocrinology & metabolism vol. (2021): 101599. doi: https://doi.org/10.1016/j.beem.2021.101599
Grinspon RP. Genetics of congenital central hypogonadism. Best Pract Res Clin Endocrinol Metab. 2021 Nov 10;101599. doi: 10.1016/j.beem.2021.101599. Epub 2021 Nov 10. PMID: 34799236.
Copy Download .nbib Format: NLM
Menopausal hormone therapy for the management of osteoporosis.

Best practice & research. Clinical endocrinology & metabolism

Gosset A, Pouillès JM, Trémollieres F.
PMID: 34119418
Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101551. doi: 10.1016/j.beem.2021.101551. Epub 2021 Jun 02.

Postmenopausal osteoporosis is a frequent clinical condition which affects nearly 1 in 3 women. Estrogen deficiency leads to rapid bone loss which is maximal within the first 2-3 years after the menopause transition and can be prevented by menopause...

Cite
Gosset A, Pouillès JM, Trémollieres F. Menopausal hormone therapy for the management of osteoporosis. Best Pract Res Clin Endocrinol Metab. 2021;35(6):101551doi: 10.1016/j.beem.2021.101551.
Gosset, A., Pouillès, J. M., & Trémollieres, F. (2021). Menopausal hormone therapy for the management of osteoporosis. Best practice & research. Clinical endocrinology & metabolism, 35(6), 101551. https://doi.org/10.1016/j.beem.2021.101551
Gosset, Anna, et al. "Menopausal hormone therapy for the management of osteoporosis." Best practice & research. Clinical endocrinology & metabolism vol. 35,6 (2021): 101551. doi: https://doi.org/10.1016/j.beem.2021.101551
Gosset A, Pouillès JM, Trémollieres F. Menopausal hormone therapy for the management of osteoporosis. Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101551. doi: 10.1016/j.beem.2021.101551. Epub 2021 Jun 02. PMID: 34119418.
Copy Download .nbib Format: NLM
Menopausal hormone therapy and breast cancer risk.

Best practice & research. Clinical endocrinology & metabolism

Rozenberg S, Di Pietrantonio V, Vandromme J, Gilles C.
PMID: 34535397
Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101577. doi: 10.1016/j.beem.2021.101577. Epub 2021 Sep 10.

This narrative review analyses the customization of Menopause Hormone Therapy in the context of breast cancer risk in women with premature ovarian insufficiency (POI) and with menopause at a normal age. Women with Idiopathic POI, FMR-1 premutation or Turner...

Cite
Rozenberg S, Di Pietrantonio V, Vandromme J, et al. Menopausal hormone therapy and breast cancer risk. Best Pract Res Clin Endocrinol Metab. 2021;35(6):101577doi: 10.1016/j.beem.2021.101577.
Rozenberg, S., Di Pietrantonio, V., Vandromme, J., & Gilles, C. (2021). Menopausal hormone therapy and breast cancer risk. Best practice & research. Clinical endocrinology & metabolism, 35(6), 101577. https://doi.org/10.1016/j.beem.2021.101577
Rozenberg, Serge, et al. "Menopausal hormone therapy and breast cancer risk." Best practice & research. Clinical endocrinology & metabolism vol. 35,6 (2021): 101577. doi: https://doi.org/10.1016/j.beem.2021.101577
Rozenberg S, Di Pietrantonio V, Vandromme J, Gilles C. Menopausal hormone therapy and breast cancer risk. Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101577. doi: 10.1016/j.beem.2021.101577. Epub 2021 Sep 10. PMID: 34535397.
Copy Download .nbib Format: NLM
Menopausal hormone therapy for the management of osteoporosis.

Best practice & research. Clinical endocrinology & metabolism

Gosset A, Pouillès JM, Trémollieres F.
PMID: 34119418
Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101551. doi: 10.1016/j.beem.2021.101551. Epub 2021 Jun 02.

Postmenopausal osteoporosis is a frequent clinical condition which affects nearly 1 in 3 women. Estrogen deficiency leads to rapid bone loss which is maximal within the first 2-3 years after the menopause transition and can be prevented by menopause...

Cite
Gosset A, Pouillès JM, Trémollieres F. Menopausal hormone therapy for the management of osteoporosis. Best Pract Res Clin Endocrinol Metab. 2021;35(6):101551doi: 10.1016/j.beem.2021.101551.
Gosset, A., Pouillès, J. M., & Trémollieres, F. (2021). Menopausal hormone therapy for the management of osteoporosis. Best practice & research. Clinical endocrinology & metabolism, 35(6), 101551. https://doi.org/10.1016/j.beem.2021.101551
Gosset, Anna, et al. "Menopausal hormone therapy for the management of osteoporosis." Best practice & research. Clinical endocrinology & metabolism vol. 35,6 (2021): 101551. doi: https://doi.org/10.1016/j.beem.2021.101551
Gosset A, Pouillès JM, Trémollieres F. Menopausal hormone therapy for the management of osteoporosis. Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101551. doi: 10.1016/j.beem.2021.101551. Epub 2021 Jun 02. PMID: 34119418.
Copy Download .nbib Format: NLM
Showing 61 to 66 of 66 entries